A cautionary tale regarding NT3 and synaptopathy:
http://www.nature.com/articles/mtm201652
They used a viral vector to induce overexpression of NT3 (I believe similar to what Genvec is doing) in normal hearing guinea pigs. Results were increased hearing thresholds and issues with the nerves and connections between nerves and hair cells. For me, this highlights a couple of things: 1) The need to know the specific type of damage - assuming this result holds up, it seems like a bad idea to increase production of NT3 if there is limited or no synaptic damage; 2) The need to have very specific targets to minimize this reorganization/disorganization.
Abstract
Synaptopathy in the cochlea occurs when the connection between inner hair cells and the auditory nerve is disrupted, leading to impaired hearing and nerve degeneration. Experiments using transgenic mice have shown that overexpression of NT3 by supporting cells repairs synaptopathy caused by overstimulation. To accomplish such therapy in the clinical setting, it would be necessary to activate the neurotrophin receptor on auditory neurons by other means. Here we test the outcome of NT3 overexpression using viral-mediated gene transfer into the perilymph versus the endolymph of the normal guinea pig cochlea. We inoculated two different
Ntf3 viral vectors, adenovirus (Adv) or adeno-associated virus (AAV) into the perilymph, to facilitate transgene expression in the mesothelial cells and cochlear duct epithelium, respectively. We assessed outcomes by comparing Auditory brainstem response (ABR) thresholds prior to that at baseline to thresholds at 1 and 3 weeks after inoculation, and then performed histologic evaluation of hair cells, nerve endings, and synaptic ribbons. We observed hearing threshold shifts as well as disorganization of peripheral nerve endings and disruption of synaptic connections between inner hair cells and peripheral nerve endings with both vectors. The data suggest that elevation of NT3 levels in the cochlear fluids can disrupt innervation and degrade hearing.